1,4-DIAZASPIRO[5.5]UNDECANE-5,9-DIONE HCL, 97.0%, 250mg

4-Chloro-3-methylisoxazol-5-amine, 98.0%, 1g

bScope BS.1152-EPLPH for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Quadruple revolver E-plan Phase 10/20/S40 S100x

7-Benzyl-4-(4-(trifluoromethyl)benzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, 98%, 100mg

2-Chlorothiazole-5-carbaldehyde, 95.0%, 1g

6-Amino-5-chloro-2-methylnicotinonitrile, 98%, 100mg

5-(Trifluoromethoxy)indole-2-carboxylic acid, 5g

(S)-2-Methoxypropan-1-amine hydrochloride, 95.0%, 5g

(4,6-Dichloropyridin-3-yl)methanol, 95.0%, 100mg

(1S,2S,3R,4R)-3-((S)-1-Acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentanecarboxylic acid, 98.0%, 1g

3-Methoxybenzylamine, 97.0%, 100g

BENZYL 2-METHYLAZEPANE-1-CARBOXYLATE, 95.0%, 2g

3',5'-Dichloro-4'-hydroxyacetophenone>98.0%(GC)(T)1g